Prince Pipes & Fittings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 28, 2025, 6:55 pm

Competitors of Prince Pipes & Fittings Ltd

All Competitor Stocks of Prince Pipes & Fittings Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:05 am

Below is a detailed analysis of the quarterly data for Prince Pipes & Fittings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 580.42 Cr.. The value appears to be declining and may need further review. It has decreased from 719.65 Cr. (Mar 2025) to 580.42 Cr., marking a decrease of 139.23 Cr..
• For Expenses, as of Jun 2025, the value is 540.85 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 664.81 Cr. (Mar 2025) to 540.85 Cr., marking a decrease of 123.96 Cr..
• For Operating Profit, as of Jun 2025, the value is 39.57 Cr.. The value appears to be declining and may need further review. It has decreased from 54.84 Cr. (Mar 2025) to 39.57 Cr., marking a decrease of 15.27 Cr..
• For OPM %, as of Jun 2025, the value is 6.82%. The value appears to be declining and may need further review. It has decreased from 7.62% (Mar 2025) to 6.82%, marking a decrease of 0.80%.
• For Other Income, as of Jun 2025, the value is 2.74 Cr.. The value appears to be declining and may need further review. It has decreased from 5.72 Cr. (Mar 2025) to 2.74 Cr., marking a decrease of 2.98 Cr..
• For Interest, as of Jun 2025, the value is 5.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.34 Cr. (Mar 2025) to 5.20 Cr., marking an increase of 1.86 Cr..
• For Depreciation, as of Jun 2025, the value is 30.75 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.28 Cr. (Mar 2025) to 30.75 Cr., marking an increase of 3.47 Cr..
• For Profit before tax, as of Jun 2025, the value is 6.36 Cr.. The value appears to be declining and may need further review. It has decreased from 29.94 Cr. (Mar 2025) to 6.36 Cr., marking a decrease of 23.58 Cr..
• For Tax %, as of Jun 2025, the value is 24.21%. The value appears to be increasing, which may not be favorable. It has increased from 19.24% (Mar 2025) to 24.21%, marking an increase of 4.97%.
• For Net Profit, as of Jun 2025, the value is 4.82 Cr.. The value appears to be declining and may need further review. It has decreased from 24.18 Cr. (Mar 2025) to 4.82 Cr., marking a decrease of 19.36 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.44. The value appears to be declining and may need further review. It has decreased from 2.19 (Mar 2025) to 0.44, marking a decrease of 1.75.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:14 pm

Growth

Last Updated: September 5, 2025, 12:40 pm

Balance Sheet

Last Updated: June 16, 2025, 11:30 am

Below is a detailed analysis of the balance sheet data for Prince Pipes & Fittings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 111.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 111.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,466.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,434.00 Cr. (Mar 2024) to 1,466.00 Cr., marking an increase of 32.00 Cr..
• For Borrowings, as of Mar 2025, the value is 277.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 130.00 Cr. (Mar 2024) to 277.00 Cr., marking an increase of 147.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 466.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 449.00 Cr. (Mar 2024) to 466.00 Cr., marking an increase of 17.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,319.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,123.00 Cr. (Mar 2024) to 2,319.00 Cr., marking an increase of 196.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 961.00 Cr.. The value appears strong and on an upward trend. It has increased from 798.00 Cr. (Mar 2024) to 961.00 Cr., marking an increase of 163.00 Cr..
• For CWIP, as of Mar 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2024) to 20.00 Cr., marking a decrease of 15.00 Cr..
• For Investments, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Mar 2024) to 27.00 Cr., marking a decrease of 11.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,312.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,252.00 Cr. (Mar 2024) to 1,312.00 Cr., marking an increase of 60.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,319.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,123.00 Cr. (Mar 2024) to 2,319.00 Cr., marking an increase of 196.00 Cr..

Notably, the Reserves (1,466.00 Cr.) exceed the Borrowings (277.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Prince Pipes & Fittings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 5. It has decreased from 14.88 (Mar 24) to 3.90, marking a decrease of 10.98.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 5. It has decreased from 16.51 (Mar 24) to 3.90, marking a decrease of 12.61.
• For Cash EPS (Rs.), as of Mar 25, the value is 13.58. This value is within the healthy range. It has decreased from 24.75 (Mar 24) to 13.58, marking a decrease of 11.17.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 142.59. It has increased from 139.69 (Mar 24) to 142.59, marking an increase of 2.90.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 142.59. It has increased from 139.69 (Mar 24) to 142.59, marking an increase of 2.90.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has increased from 0.00 (Mar 24) to 0.50, marking an increase of 0.50.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 228.28. It has decreased from 232.34 (Mar 24) to 228.28, marking a decrease of 4.06.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 15.88. This value is within the healthy range. It has decreased from 29.26 (Mar 24) to 15.88, marking a decrease of 13.38.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.20. This value is within the healthy range. It has decreased from 21.01 (Mar 24) to 6.20, marking a decrease of 14.81.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.32. This value is within the healthy range. It has decreased from 22.05 (Mar 24) to 5.32, marking a decrease of 16.73.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.90. This value is within the healthy range. It has decreased from 16.51 (Mar 24) to 3.90, marking a decrease of 12.61.
• For PBDIT Margin (%), as of Mar 25, the value is 6.95. This value is below the healthy minimum of 10. It has decreased from 12.59 (Mar 24) to 6.95, marking a decrease of 5.64.
• For PBIT Margin (%), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 10. It has decreased from 9.04 (Mar 24) to 2.71, marking a decrease of 6.33.
• For PBT Margin (%), as of Mar 25, the value is 2.33. This value is below the healthy minimum of 10. It has decreased from 9.48 (Mar 24) to 2.33, marking a decrease of 7.15.
• For Net Profit Margin (%), as of Mar 25, the value is 1.70. This value is below the healthy minimum of 5. It has decreased from 7.10 (Mar 24) to 1.70, marking a decrease of 5.40.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 15. It has decreased from 11.81 (Mar 24) to 2.73, marking a decrease of 9.08.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.00. This value is below the healthy minimum of 10. It has decreased from 14.43 (Mar 24) to 4.00, marking a decrease of 10.43.
• For Return On Assets (%), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 5. It has decreased from 8.59 (Mar 24) to 1.85, marking a decrease of 6.74.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.05, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has increased from 0.07 (Mar 24) to 0.16, marking an increase of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has decreased from 1.29 (Mar 24) to 1.14, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has decreased from 2.43 (Mar 24) to 2.12, marking a decrease of 0.31.
• For Quick Ratio (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.58 (Mar 24) to 1.11, marking a decrease of 0.47.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.82. This value is within the healthy range. It has increased from 4.06 (Mar 24) to 4.82, marking an increase of 0.76.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 25.63. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 25.63, marking an increase of 25.63.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.36. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 7.36, marking an increase of 7.36.
• For Earning Retention Ratio (%), as of Mar 25, the value is 74.37. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 74.37, marking an increase of 74.37.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.64. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 92.64, marking an increase of 92.64.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 18.15. This value is within the healthy range. It has decreased from 49.77 (Mar 24) to 18.15, marking a decrease of 31.62.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.46. This value is within the healthy range. It has decreased from 26.32 (Mar 24) to 5.46, marking a decrease of 20.86.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,894.31. It has decreased from 6,111.50 (Mar 24) to 2,894.31, marking a decrease of 3,217.19.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 2.38 (Mar 24) to 1.15, marking a decrease of 1.23.
• For EV / EBITDA (X), as of Mar 25, the value is 16.49. This value exceeds the healthy maximum of 15. It has decreased from 18.89 (Mar 24) to 16.49, marking a decrease of 2.40.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 2.36 (Mar 24) to 1.07, marking a decrease of 1.29.
• For Retention Ratios (%), as of Mar 25, the value is 74.36. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 74.36, marking an increase of 74.36.
• For Price / BV (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 3.93 (Mar 24) to 1.72, marking a decrease of 2.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 2.36 (Mar 24) to 1.07, marking a decrease of 1.29.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness